Status:
COMPLETED
Surveillance Imaging Modalities for Breast Cancer Assessment
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Dartmouth College
Harvard Pilgrim Health Care
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to determine the effectiveness of surveillance breast MRI compared to mammography alone in women with a personal history of breast cancer
Detailed Description
Our overall aim is to find out how well MRI works compared with mammography for surveillance in women who have previously had breast cancer. Specifically, our goals are to: 1. Understand doctors' and...
Eligibility Criteria
Inclusion
- Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis between January 1, 2005 and December 31, 2012.
- \-
Exclusion
- Women with a diagnosis of lobular carcinoma in situ
- Women with missing cancer staging data from Surveillance, Epidemiology and End Results (SEER) Program records
- Women with Stage 4 breast cancer at time of diagnosis
- Women with a diagnosis of a second breast cancer event within six months of the primary diagnosis
- Women who die within six months of primary diagnosis
- Women who have had a double mastectomy
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
36444 Patients enrolled
Trial Details
Trial ID
NCT02212834
Start Date
October 1 2013
End Date
November 1 2016
Last Update
August 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.